Barclays
PMVP icon

Barclays’s PMV Pharmaceuticals PMVP Stock Holding History

Barclays’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46K Sell
27,536
-225
-0.8% -$291 ﹤0.01% 4598
2026
Q2 		$37.2K Buy
27,761
+225
+0.8% +$289 ﹤0.01% 4412
2026
Q1 		$34.1K Hold
27,536
– – ﹤0.01% 4440
2025
Q4 		$34.4K Hold
27,536
– – ﹤0.01% 4797
2025
Q3 		$38.6K Sell
27,536
-2,661
-9% -$3.68K ﹤0.01% 4831
2025
Q2 		$32K Hold
30,197
– – ﹤0.01% 4776
2025
Q1 		$32.9K Hold
30,197
– – ﹤0.01% 4701
2024
Q4 		$45.6K Sell
30,197
-51
-0.2% -$81 ﹤0.01% 4780
2024
Q3 		$45.1K Sell
30,248
-434,704
-93% -$672K ﹤0.01% 4769
2024
Q2 		$753K Sell
464,952
-28,598
-6% -$51.6K ﹤0.01% 2773
2024
Q1 		$839K Sell
493,550
-23,814
-5% -$44.5K ﹤0.01% 3251
2023
Q4 		$1.6M Buy
517,364
+46,352
+10% +$123K ﹤0.01% 3091
2023
Q3 		$2.89M Buy
471,012
+230,692
+96% +$1.59M ﹤0.01% 1675
2023
Q2 		$1.5M Sell
240,320
-15,602
-6% -$81.8K ﹤0.01% 2066
2023
Q1 		$1.22M Buy
255,922
+93,603
+58% +$659K ﹤0.01% 2580
2022
Q4 		$1.41M Sell
162,319
-31,552
-16% -$336K ﹤0.01% 2522
2022
Q3 		$2.31M Buy
193,871
+71,120
+58% +$1.03M ﹤0.01% 1648
2022
Q2 		$1.75M Buy
122,751
+114,042
+1,309% +$1.66M ﹤0.01% 1950
2022
Q1 		$182K Buy
+8,709
New +$154K ﹤0.01% 3479

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Accurate Wealth Management
Accurate Wealth Management Wesley Chapel, Florida $1.16B AUM 24.67% 1-Year Est. Return
Silver Grove Financial Group
Silver Grove Financial Group Orchard Park, New York $214M AUM 19.83% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Barclays's PMVP Position: Q3 2026 in Review

Barclays reduced its PMV Pharmaceuticals (PMVP) stake by 0.81% in Q3 2026, selling an estimated $291 and leaving 27,536 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #4598.

Barclays first reported a position in PMVP in Q1 2022 and has held it in 19 quarters since. The position peaked at $2.89M in Q3 2023. 9 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.

  • Barclays held 27,536 shares of PMV Pharmaceuticals worth $46K as of Q3 2026.
  • Barclays sold 225 PMV Pharmaceuticals shares in Q3 2026, an estimated $291.
  • PMV Pharmaceuticals made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4598 holding.
  • Barclays first reported a position in PMV Pharmaceuticals in Q1 2022 and has held it in 19 quarters since.
  • Barclays's PMV Pharmaceuticals position peaked at $2.89M in Q3 2023.
  • 9 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.